gonorrhea BD Gets CE Mark, Australian Regulatory Approval for New Cor MX Instrument The new MX instrument, which is based on the firm's BD Max PCR instrument, is the final component of the high-throughput BD Cor system. STIs Reached Record Highs, Then COVID-19 Hit. Test Makers Now Ponder What's Next Premium As the pandemic continues to play out, test developers aren't sure how it will impact STIs and their work around developing and manufacturing tests. Visby Medical Anticipates Rapid Uptake of Handheld PCR Test for STIs Premium The firm received clearance and CLIA waiver for a 30-minute point-of-care PCR assay for three common STIs earlier this week. Visby Medical Obtains FDA 510(k), CLIA Waiver for Multiplex STI Test Using Handheld PCR Device The CLIA waiver enables clinicians to run a 30-minute multiplex test for chlamydia, gonorrhea, and trichomonas during a patient's visit. JHU Researchers Develop 15-Minute PCR System, Drug-Resistant Gonorrhea Test Premium The Hopkins team expects to spinout a company soon in order to commercialize the technology in the next two to three years. Apr 8, 2021 CLIA Waiver in Hand, Binx Health Targeting Retailers, Urgent Care Centers With STI Tests Premium Apr 6, 2021 CARB-X Commits up to $13.8M to Novel Microdevices for Point-of-Care STI Test Mar 30, 2021 Binx Health Chlamydia and Gonorrhea Test CLIA Waived Sep 9, 2020 Visby Medical Takes on STI, COVID-19 Testing With Single-Use PCR Machine Premium Aug 5, 2020 Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition Jun 16, 2020 Roche, SpeeDx Partner to Expand Access to Antibiotic Resistance Tests Apr 30, 2020 FDA Provides Second Clearance for Binx MDx Platform Feb 11, 2020 New York State Approves Enzo Biochem STI Tests on GenFlex Platform Nov 19, 2019 Rheonix Submits MDx System, Triplex Sexually Transmitted Infections Test to FDA Nov 7, 2019 SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs Nov 4, 2019 Shield Bio Brings Nanopore Sequencing to Patients Through STI Test Service Premium Oct 15, 2019 Enzo Biochem Fiscal Q4 Revenues Down 8 Percent Sep 6, 2019 As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow Premium Aug 27, 2019 After Years of Groundwork, Rapid STI MDx Space is Inaugurated With Binx FDA Clearance Premium Aug 12, 2019 FDA Clears Binx Health Point-of-Care Testing Platform for Chlamydia, Gonorrhea Aug 5, 2019 SpeeDx Raises $15M in Equity Investment Jul 11, 2019 Enzo Biochem Gets NY Approval for Oral, Rectal CT/NG Test; Updates Lab Business Models May 24, 2019 Startup Novel Microdevices Developing Rapid Point-of-Care MDx System for STIs Premium May 23, 2019 FDA Clears Cepheid, Hologic CT/NG Assays for Extragenital Testing May 15, 2019 Binx Health Targeting Broader STI Screening With Rapid POC Platform Premium Load More Breaking News Myasthenia Gravis Study Identifies Genetic Risk Loci Affecting Acetylcholine Receptor Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA Illumina, National Cancer Center Japan Collaborate on Nasopharyngeal Cancer Study Fluidigm Obtains $250M Investment, Changing Name to Standard BioTools SeqOne Genomics Closes €20M Series A Financing NeoGenomics Partners With Biomarker Collaborative to Provide Lung Cancer Resources The Scan For STEM Students to Stay New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports. To Inform or Not, To Know or Not The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information. Rapid Test Studies Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says. PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.